Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Opinion
When Terminal Cancer Patients Don't Get the Message
Publish date:
November 2, 2012
Dr. Freed is a psychologist in Santa Barbara, Calif., and a medical journalist.
Pages
« first
1
2
Recommended Reading
FDA: Continue Study of Antinerve Growth Factors for Pain
MDedge Hematology and Oncology
Music Interventions Improve Anxiety, Pain in Cancer Patients
MDedge Hematology and Oncology
'Scrambler' Device Reduces Refractory Neuropathic Pain
MDedge Hematology and Oncology
Ketamine Relieves Pain at End of Life
MDedge Hematology and Oncology
Duloxetine Eases Pain of Chemo-Induced Neuropathy
MDedge Hematology and Oncology
Vitamin D Eases Aromatase Inhibitor-Related Arthralgia
MDedge Hematology and Oncology
Mass. Insurer Clamps Down on Opioid Prescriptions
MDedge Hematology and Oncology
Methadone Deaths Outpace Mortality for Other Opioids
MDedge Hematology and Oncology
FDA Approves REMS for Long-Acting Opioids
MDedge Hematology and Oncology
Pain Scales: What to Ponder When Making Your Pick
MDedge Hematology and Oncology
All Specialties